Ernst-Guenter Afting Insider Profile
4 Followers
Ernst-Guenter Afting, Director at Enanta Pharmaceuticals, holds 17.29K shares in Enanta Pharmaceuticals (Ticker: ENTA), holds 917.93K shares in Sorrento Therapeutics (Ticker: SRNE), holds 97.50K shares in Sequenom (Ticker: SQNM). Most recently, Ernst-Guenter Afting Sold ― shares of Enanta Pharmaceuticals on Dec 13, 2013 for an estimated value of $554.61K.
Ernst-Guenter Afting's Trading History
You May Also Like
Ernst-Guenter Afting insider profile FAQ
What is the percentage of profitable transactions made by Ernst-Guenter Afting?
The percentage of profitable transactions made by Ernst-Guenter Afting is 50%.
What is the average return per transaction made by Ernst-Guenter Afting?
The average return per transaction made by Ernst-Guenter Afting is 34.30%.
What stocks does Ernst-Guenter Afting hold?
Ernst-Guenter Afting holds: ENTA, SRNE, SQNM stocks.
What was Ernst-Guenter Afting’s latest transaction?
Ernst-Guenter Afting’s latest transaction was an Informative Sell of $554.61K.
What was Ernst-Guenter Afting's most profitable transaction?
Ernst-Guenter Afting’s most profitable transaction was an Informative Buy of SRNE stock on February 18, 2011. The return on the trade was 85.00%.
What is Ernst-Guenter Afting's role in Enanta Pharmaceuticals?
Ernst-Guenter Afting's role in Enanta Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
